FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Schrödinger, Inc. Stock AnalysisComprehensive stock analysis for Schrödinger, Inc. (SDGR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSDGR
SDGR
Schrödinger, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SDGR
Home🔹Stocks🔹Schrödinger, Inc.

Schrödinger, Inc.

🇺🇸SDGR•NASDAQ

Schrödinger, Inc.

🇺🇸SDGR•NASDAQ
Market cap
$1.42B
Sentiment

Your view on SDGR

Mkt Cap
$1.42B
Sentiment
Your view
SDGR
Schrödinger, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SDGR
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Schrödinger, Inc.

Industry
Software - Application
Sector
Technology
CEO
Ramy Farid
Headquarters
1540 Broadway, New York City, NY, US
Industry
Software - Application
Sector
Technology
CEO
Ramy Farid
Headquarters
1540 Broadway, New York City, NY, US
Description

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery.

The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.

The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Schrödinger, Inc., and the rating behind it. SDGR last traded at $19.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Schrödinger, Inc.. Starting points for Schrödinger, Inc.: EPS -$0.73, beta 1.69 — an Software - Application name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Schrödinger, Inc.. Schrödinger, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Schrödinger, Inc.. Trailing twelve-month EPS for Schrödinger, Inc. stands at -$0.73. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Schrödinger, Inc.. Schrödinger, Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Schrödinger, Inc. valued side by side against its closest peers. Schrödinger, Inc. is measured against Software - Application peers within the Technology sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Schrödinger, Inc., and how their positions are changing. At a $1.42B market value, institutional positions materially move Schrödinger, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Schrödinger, Inc. executives and directors. Shares of Schrödinger, Inc. have traded between $16.60 and $28.47 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Schrödinger, Inc.. Schrödinger, Inc. is a $1.42B Technology company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Schrödinger, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Schrödinger, Inc.. Coverage tracks Schrödinger, Inc. within Software - Application (Technology). Press releases and market coverage, newest first.

Peer companies

  • ABCL — AbCellera Biologics Inc.
  • AZTA — Azenta, Inc.
  • EVO — Evotec SE
  • IMNM — Immunome, Inc.
  • OMCL — Omnicell, Inc.
  • OMDA — Omada Health
  • PGNY — Progyny, Inc.
  • PHR — Phreesia, Inc.

More Software - Application companies

  • API — Agora, Inc.
  • APP — AppLovin Corporation
  • APPF — AppFolio, Inc.
  • APPS — Digital Turbine, Inc.
  • APPZ — Monster Arts, Inc.
  • APTY — APT Systems, Inc.
  • APVS — Applied Visual Sciences, Inc.
  • AQIA — Aquiva Group Inc.
  • ARAI — Arrive AI Inc.
  • ARCS — Arcis Resources Corporation
  • ARGHF — Argo Corporation
  • ARQQ — Arqit Quantum Inc.

ETFs holding Schrödinger, Inc.

  • LRNZ — TRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF (3.46%)
  • ARKG — ARK Genomic Revolution ETF (2.24%)
  • HEAL — Global X - HealthTech ETF (1.02%)
  • PSCH — Invesco S&P SmallCap Health Care ETF (0.56%)
  • EKG — First Trust Nasdaq Lux Digital Health Solutions ETF (0.46%)
  • LGHT — Langar Global HealthTech ETF (0.28%)
  • IHF — iShares US Healthcare Providers ETF (0.16%)

News

Latest Market News